<?xml version="1.0"?>
<Articles JournalTitle="Traditional and Integrative Medicine">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Traditional and Integrative Medicine</JournalTitle>
      <Issn>2476-5104</Issn>
      <Volume>6</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2021</Year>
        <Month>12</Month>
        <Day>27</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Antioxidant and Anticancer Activities of Anethum graveolens L., Citrus limon (L.) Osbeck and Zingiber officinale Roscoe Essential Oils</title>
    <FirstPage>333</FirstPage>
    <LastPage>347</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mahmoud</FirstName>
        <LastName>Osanloo</LastName>
        <affiliation locale="en_US">Department of Medical Nanotechnology, Schools of Advanced Medicine in Technologies, Fasa University of Medical Sciences, Fasa, Iran AND Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Ghanbariasad</LastName>
        <affiliation locale="en_US">Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran AND Department of Medical Biotechnology, Schools of Medicine, Fasa University of Medical, Fasa, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Taghinezhad</LastName>
        <affiliation locale="en_US">Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>08</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Since synthetic chemotherapeutic drugs produce a certain degree of drug resistance and due to their common side effects, such as damage to hematopoietic cells and hair loss, it is necessary to use herbal medicine as a substrate to develop new anticancer drugs. The ingredients of three essential oils (EO) were identified using gas chromatography&#x2013;mass spectrometry (GC-MS) analysis. Their anticancer activities have been investigated on four human breast cancer cell lines, including MCF-7, MDA-MB-175, MDA-MB-231, and MDA-MB-468. In addition, their antioxidant activity was evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. The three plants were investigated for identifications of the ingredients of their EOs, and major ingredients were identified in each plant as alpha-phellandrene (26.75 %) in Anethum graveolens L., limonene (61.83 %) in Citrus limon (L.) Osbeck, and zingiberene (30.28 %) in Zingiber officinale Roscoe. Among the EOs, C. limon was significantly more effective than others; its half-maximal inhibitory concentration (IC50) on MCF-7 was obtained at 201 &#xB5;g.mL-1. Furthermore, Z. officinale EO showed a higher antioxidant activities in comparison to the two other EOs. Considering the antioxidant and anticancer effects of the EOs, they could be further investigated as a possible complementary medicine in cancer.</abstract>
    <web_url>https://jtim.tums.ac.ir/index.php/jtim/article/view/387</web_url>
  </Article>
</Articles>
